Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1677
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18028050 | DONOR HEMATOPOIETIC CELL CHIMERISM AND ORGAN AND TISSUE TRANSPLANTATION AND AUTOIMMUNE TOLERANCE | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18269813 | TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18190068 | Compositions and Methods for Adjuvanted Vaccines | Non-Final OA | Massachusetts Institute of Technology |
| 18249661 | METHODS FOR GENERATING FORMATIVE PLURIPOTENT STEM CELLS COMPETENT FOR DIRECT PRIMORDIAL GERM CELL INDUCTION | Final Rejection | The Board of Regents of The University of Texas System |
| 18459209 | MULTI-ARMED MYXOMA VIRUS | Non-Final OA | Arizona Board of Regents for and on behalf of Arizona State University |
| 18265609 | METHOD FOR PRODUCING PLURIPOTENT STEM CELL POPULATION | Final Rejection | RIKEN |
| 17638753 | ORGANOID MESODERM LINEAGE DIVERSIFICATION | Final Rejection | RIKEN |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy